Dichloromethane → (S)-1-(4-(4-(3-methylmorpholino)pyrimidin-2-yl)phenyl)-3-(pyridin-4-yl)urea
Reaction equation
Cl[C:2]1[N:7]=[C:6]([N:8]2[CH2:13][CH2:12][O:11][CH2:10][C@@H:9]2[CH3:14])[CH:5]=[CH:4][N:3]=1.[N:15]1[CH:20]=[CH:19][C:18]([NH:21][C:22]([NH:24][C:25]2[CH:30]=[CH:29][C:28](B3OC(C)(C)C(C)(C)O3)=[CH:27][CH:26]=2)=[O:23])=[CH:17][CH:16]=1.C([O-])([O-])=O.[Na+].[Na+].C(Cl)Cl>COCCOC.O.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2]>[CH3:14][C@@H:9]1[N:8]([C:6]2[CH:5]=[CH:4][N:3]=[C:2]([C:28]3[CH:27]=[CH:26][C:25]([NH:24][C:22]([NH:21][C:18]4[CH:17]=[CH:16][N:15]=[CH:20][CH:19]=4)=[O:23])=[CH:30][CH:29]=3)[N:7]=2)[CH2:13][CH2:12][O:11][CH2:10]1Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
(S)-4-(2-chloropyrimidin-4-yl)-3-methylmorpholine (intermediate 3) (100 mg, 0.47 mmol) was stirred with 1-(pyridin-4-yl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea (intermediate 30) (175 mg, 0.52 mmol), Na2CO3 (149 mg, 1.4 mmol) and Pd(dppf)Cl2:DCM (19 mg, 0.02 mmol) in DME:Water (4:1)(5 ml) for 30 mins at 130° C. in a microwave. The reaction mixture was filtered through a celite545 cake and washed with methanol. The solvent was removed in vacuo and the crude residue was purified by prep HPLC at high pH. Further purification was achieved using an SCX-2 cartridge yielding the title compound. (32 mg, 17%)
Workup
- filtrationThe reaction mixture was filtered through a celite545 cake
- washwashed with methanol
- customThe solvent was removed in vacuo
- customthe crude residue was purified by prep HPLC at high pH
- customFurther purification
Sources & evidence
- ORD record
- ord-3663025fa057463b86756095fa7e3500
- Source dataset
- uspto-grants-2016_02
- Patent number
- US09249129B2
Reaction notes
Loading…